NCT00242359View on ClinicalTrials.gov

A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Allergy Induced Asthma
Interventions
DRUG

omalizumab

Sponsors
All Listed Sponsors
lead

Bernstein Clinical Research Center

OTHER